$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
来那度胺多久起效?
2025-10-19 11:44:20
Check Details
多发性骨髓瘤吃来那度胺能活多久?
2025-10-19 11:44:20
Check Details
来那度胺治疗多发性骨髓瘤需要几个疗程?
2025-10-19 11:44:20
Check Details
多发性骨髓瘤使用来那度胺治疗的效果
2025-10-19 11:44:20
Check Details
来那度胺多久耐药?
2025-10-19 11:44:20
Check Details
苯达莫司汀和美罗华有什么区别
2025-10-19 11:44:20
Check Details
多发性骨髓瘤药物卡非佐米(Carfilzomib)用要注意事项
2025-10-19 11:44:20
Check Details
卡非佐米(Carfilzomib)是什么药物?
2025-10-19 11:44:20
Check Details
卡非佐米(Carfilzomib)一个疗程多少钱?
2025-10-19 11:44:20
Check Details
多发性骨髓瘤药物卡非佐米(Carfilzomib)注射方法
2025-10-19 11:44:20
Check Details
卡非佐米进入医保了吗?
2025-10-19 11:44:20
Check Details
卡非佐米一个疗程多长时间?
2025-10-19 11:44:20
Check Details
1
2
...
7137
7138
7139
7140
7141
7142
7143
...
10215
10216
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pirtobrutinib: A Novel Non-Covalent BTK Inhibitor for Relapsed Hematologic Malignancies
2
Clinical Application and Safety Monitoring of Revumenib (Menin Inhibitor) in Acute Leukemia
3
FDA Accelerates Approval of Zongertinib: Precision Medicine Advancement for HER2-Mutated NSCLC
4
Ixazomib & Pomalidomide in Multiple Myeloma: Mechanisms & Clinical Insights
5
Etrasimod (Velsipity™): A Selective S1P Modulator Transforming Ulcerative Colitis Treatment
6
Delgocitinib Cream for Vitiligo: Mechanism, Potential, and Current Evidence
7
Sotorasib (Lumakras®): The First KRAS Inhibitor Revolutionizing Non-Small Cell Lung Cancer Treatment
8
ROS and Cancer: The Potential of Natural Antioxidants
9
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
10
Breaking the Bottleneck: KOSELUGO® (Selumetinib) Reshapes the Treatment Landscape for Neurofibromatosis Type 1 (NF1)
11
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
12
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy